Optical coherence tomography angiography (OCT-A) is an emerging technology that allows for the non-invasive imaging of the ocular microvasculature. Despite the wealth of observations and numerous research studies illustrating the potential clinical uses of OCT-A, this technique is currently rarely used in routine clinical settings. In this review, technical and clinical aspects of OCT-A imaging are discussed, and the future clinical potential of OCT-A is considered. An understanding of the basic principles and limitations of OCT-A technology will better inform clinicians of its future potential in the diagnosis and management of ocular diseases.
Optical coherence tomography angiography (OCT-A) is a recent functional extension of optical coherence tomography (OCT), which visualises vasculature by detecting the erythrocytes in motion within the vessel walls. By comparing repeated OCT B-scans, it is possible to image blood flow by examining differences among the scans. The technique has attracted considerable interest from clinicians and scientists alike. Hence, several reviews have focused either on technical aspects of the technology [1] [2] [3] [4] or on the multiple potential clinical applications of this approach. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] However, the single clinical application that makes OCT-A an indispensable tool remains ill-defined. In addition to discussing the technical and clinical aspects of OCT-A, this review highlights the potential future directions of this technology and determines what is required to integrate OCT-A imaging into real-world clinical practice.
Algorithms and image artefacts of OCT-A
OCT-A identifies areas of motion that correlate with vascular flow based on the decorrelation signal from repeated B-scans (n ≥ 2), where numerous approaches of decorrelation have been proposed. A single OCT B-scan contains both the intensity as well as the phase information of the sample, resulting from Fourier transformation of the interferometer output signal. Therefore, current OCT-A algorithms can broadly be classified as utilising either the amplitude, phase, or complex OCT signal to perform the calculation. For example, Jia et al. proposed an averaging scheme to compute intensity-based OCT-A from several sub-spectra of the light source, and then transfer the split-spectrum idea on to phase data. 18 Commercial OCT-A systems, dependent on their acquisition speed and system phase stability, implement different angiogram algorithms.
For example, AngioVue (OptoVue, Fremont, California, USA) uses a split-spectrum amplitude-decorrelation angiography algorithm with two repeated B-scans, 19 whereas PLEX Elite (Zeiss, Dublin,
To improve visualisation and segmentation of microvessels, angiographic images are often enhanced by vascular structure enhancement algorithms. These signal-tonoise ratio analyses typically suppress noise in physiological signals, which is needed for quantification analysis. Classical denoising methods -such as the Gaussian filter, compressive sensing 20 and Bayesian estimation 21 -suppress the speckle noise in the image while preserving the vascular information. Specifically, vessel-targeted methods -such as Frangi filter, 22 Gabor filter 23 and coherence filter 24 -detect the local vessel orientation and also enhance the visualisation of the vessel by maximising the 'vesselness' signal. Recently, a modified Bayesian residual transform method 25 was used to decompose the original image to several residual images with different scales, whereby each scale was independent from one another.
Results showed that it is feasible to utilise the modified Bayesian residual transform method 25 for processing physiological signals for tasks such as noise suppression in OCT and OCT-A images. Image artefacts have been an important topic of research in nearly all medical imaging modalities. A critical element of interpretation of an OCT-A image is to ensure that the information or finding is real and not due to noise or artefact. An artefact is a feature appearing in an angiographic image that is not present in the original entity. Artefacts may either be very obvious or just a few pixels out of balance. Failure to properly recognise image artefacts may lead to misdiagnosis and improper management of a disease. Image quality of OCT-A can be compromised by several artefacts.
Projection artefacts occur when shadowing of larger branches of the central retinal artery appear in the OCT-A angiograms of the deeper retinal layer and choriocapillaris layer. This is because the light reaching the deeper tissue is being transmitted through the superficial tissue; thus, its intensity is related to the scattering properties of the superficial tissue. Therefore, the superficial blood flow will cast a 'shadow' in its axial direction below and affect the visualisation and quantification of the angiogram in deeper layers ( Figure 1A-C) .
Novel methods have been proposed to tackle projection artefacts -in particular, by simply removing the flow signals of the projections by subtracting the deeper layer angiogram from the superficial angiogram, 26 or by comparing the vascular signal intensity in each A-scan. 27 However, none of these methods is able to preserve the integrity and continuity of deep vascular networks. Hence, there is a pressing need to develop an algorithm that removes projection artefacts yet retains deeper vascular information. Motion artefacts are lateral displacements of the image, leading to misalignment of the vessels on the OCT-A image ( Figure 1D ). These are commonly caused by involuntary eye movements and cardiac motion, often unavoidable during OCT-A imaging. Bulk motion affects the single Bscan vascular extraction as well as the quality of en face angiogram. The introduction of an inbuilt eye tracker has significantly reduced excessive motion artefacts and preserved the quality of the angiogram. However, small-scale motion compensation remains a challenge and can be seen as a single solid line, dual vessel, or vessel discontinuity on the en face angiogram.
Furthermore, patients who have ocular pathologies tend to have poor fixation, resulting in excessive eye motions. 28 For such cases, the eye tracker will prolong image acquisition time and may even increase the artefacts due to small-scale motion. Low image contrast is a result of either low signal-to-noise of the system, poor beam alignment, opaque media (cornea and/or crystalline lens), or defocus of the laser beam ( Figure 1D , E). In general, the higher the signal level, the more useful information is within the image, and it is therefore weighted more heavily than the lower level noise. It is also important to realise that in spectral domain-OCT systems, the sensitivity decreases during deeper tissue imaging (such as, choroid), and the signal roll-off can be 10-15 dB from zero-delay line to 1 mm. Hence, during scanning, positioning the retina close to the bottom of the image can severely lower the signal-to-noise ratio of the image. 
Segmentation of OCT-A
Segmentation error occurs when the OCT-A software encounters problems in detecting the inner and outer limits of the retinal or choroidal layers. This leads to a deviation of the slab and consequent errors in automated measurements. An accurate delineation of slab boundaries is crucial for en face angiogram visualisation and quantification, and a poorly segmented OCT-A can lead to disease misdiagnosis.
The majority of the commercial OCT-A systems provide an inbuilt segmentation algorithm. These commercial algorithms can usually provide accurate segmentation of the inner limited membrane and retinal pigmented epithelium layer. However, the ability of the segmentation algorithms reduces considerably in the presence of excessive eye motions, inter-individual anatomical variations of the optic nerve head regions, and areas greatly affected by eye diseases (such as age-related macular degeneration, diabetic retinopathy or high myopia; Figure 2 ). Manual and semi-automated segmentation, although more precise, require specific training and are very labour intensive. Therefore, manual or semi-automatic segmentation algorithms are impractical, especially in large cohort studies.
Automated segmentation methods can be based either on fixed model or machine/ deep learning. Fixed model-based methods include peak searching in A-scan, 29 adaptive
thresholding, Markov boundary model, 30 active contour, 31, 32 texture and shape analysis, 33 3-D theoretical representation fitting, 34 sparse high order potentials, 35 graph theory and dynamic programming. 36 These techniques are fed with presumed layer structure and intensity information and are hence sensitive to system parameters as well as data formats. In recent years, machine/deep learning have demonstrated power capacity in biomedical imaging segmentation, and showed superior performance compared to the fixed model methods. These machine learning and deep learning approaches pick the specific characteristics from the training dataset, and then either apply layer segmentation directly on the validation dataset, or supervise the testing procedure in a teacher-student model to improve iteratively the classifier model. Early investigations include support vector machine, 37, 38 random forest, 39 and neural network, 40 and more recently, convolutional neural networks, such as U-Net 41 and ReLayNet, 42 and have been used for retinal layer segmentations in healthy subjects and agerelated macular degeneration patients. 43, 44 Recent studies have proposed classification systems for the different types of artefacts in OCT-A images. 28, 45, 46 However, very few studies have looked systematically into the relative frequency of artefacts in OCT-A images. 45 Chen et al.
evaluated the number of choroidal OCT-A scans and found that such artefacts are extremely frequent, with projection artefacts and motion artefacts being present in 100 per cent of the cases. 45 This agrees with Lauermann et al. who showed that both motion artefacts and segmentation errors are frequent and occur more frequently in patients with macular diseases, in whom fixation aptitudes are considerably compromised. 47 
Applications in retinal disease
Diabetic retinopathy is a condition which has profound effects on the retinal microvasculature, 48 and the leading cause of new cases of blindness in the middleaged and elderly worldwide. Therefore, OCT-A may be useful in this respect. Most diabetic retinopathy classification systems such as the modified Airlie house classification or the international clinical disease severity scale rely solely on the pathological features seen on fundus photographs. 49 For the classification of macula oedema, a wide variety of OCT-based classification systems has been proposed, relying either on morphological features or quantitative measures.
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Recent OCT-A studies have highlighted the contribution of the deep capillary plexus to the oxygen requirements of the photoreceptors, as well as the outer retina, in diabetic macular ischaemia. Two studies reported that in diabetic retinopathy, eyes with macular photoreceptor disruption corresponded to areas of deep capillary plexus non-perfusion. 51, 52 Another study showed that the long-term recovery of photoreceptors integrity and the visual outcome of patients with diabetic macular oedema was significantly better in eyes with a more perfused deep capillary plexus. 53 These studies support the preclinical findings in animal studies that, apart from choroidal circulation, photoreceptors also receive 15 per cent of oxygen via diffusion from the inner retinal circulation of the deep capillary plexus. 54 In addition, it suggests that chronic ischaemia at the deep capillary plexus seen in diabetic retinopathy, may play an important role in photoreceptor damage. Given the depth-resolved nature of OCT-A, it is possible to learn more about various retinal vascular layers in diabetes as compared to fluorescein angiography that mainly images the superficial retinal capillary plexus and thus is unable to evaluate the deep retinal capillary plexus in great detail. This is important because histopathology indicates that this is an early site of damage in diabetic retinopathy. 55 Indeed, several studies have concurred on this. 52, [56] [57] [58] However, the degree to which these vascular changes are related to visual acuity levels or to the risk of visual loss remains unknown. Vascular abnormalities in the deep plexus do correspond with anatomic changes in the underlying retina, such as disorganisation of inner retinal layers, and also occur in regions of macular oedema development. 59 Also intriguing is the capillary dropout at the level of the deeper retinal plexus, which is also seen in patients with systemic hypertension. 60 One clinic-based observational study showed that in 77 non-diabetic hypertensive adults, higher 24-hour ambulatory blood pressure was correlated with sparser density of vessels at the deep capillary plexus. 60 A limitation of current commercial OCT-A compared to fluorescein angiography is the relatively limited field of view, which can make it unsuitable for evaluation of peripheral areas of capillary dropout or peripheral neovascularisation in diabetic patients. This can be partially overcome by obtaining multiple images and montaging them together. 61 In addition, fast OCT systems can image areas of up to 12 × 12 mm 62 and prototype system with angles up to 100 have been realised. 63 Microaneurysms are hallmarks of diabetic retinopathy and can be visualised with OCT-A, mostly seen in the intermediate and deep capillary plexuses. 56, 64, 65 However, not all microaneurysms are visible on OCT-A. This is most likely a result of slow blood flow, which is below the level of detection of OCT-A. Conversely, smaller microaneurysms which can be detected with OCT-A may not be seen with classical angiography because of limited resolution or dye leakage. OCT-A can also be used to visualise retinal neovascularisation, which is seen to project into the vitreous cavity ( Figure 3 ).
66,67
In patients with retinal vein occlusion and retinal artery occlusion, OCT-A has so far been of limited value, partially because of segmentation errors associated with the retinal signs. For example, in retinal vein occlusion, segmentation errors are associated with haemorrhages and macular oedema, whereas in retinal artery occlusion, segmentation errors are associated with capillary drop-out and inner retinal layer swelling. In branch retinal vein occlusion, increased parafoveal capillary nonperfusion and decreased parafoveal vessel density were reported, the latter associated with bestcorrected visual acuity. 68 OCT-A has been extensively used in both non-neovascular and exudative age-related macular degeneration. In non-neovascular age-related macular degeneration, an increase in choriocapillaris flow voids was observed with increasing numbers of drusen 69 and reticular pseudodrusen. 70 In keeping with histology samples, pronounced choriocapillaris flow impairment is seen below geographic atrophy lesions. 71 At the margin of geographic atrophy, choriocapillaris flow defects can be seen in many cases. 72, 73 This indicates that changes in the choriocapillaris may precede retinal pigmented epithelium loss and expansion of geographic atrophy can occur in these areas. However, longitudinal studies are required to prove this hypothesis. Perhaps the most immediate clinical application of OCT-A is in the detection and management of choroidal neovascularisation (Figure 4) . Based on the anatomical location of new vessel growth -either below the retinal pigmented epithelium layer (type 1 or occult choroidal neovascularisation); between the retinal pigmented epithelium layer and the retina (type 2 or classic choroidal neovascularisation); or starting within the retina and anastomosing with the choroidal circulation (type 3 or retinal angiomatous proliferation) 74 -all subtypes of choroidal neovascularisation can be detected with OCT-A. [75] [76] [77] [78] [79] One major difficulty of diagnosing choroidal neovascularisation on OCT-A is identifying artefacts that may create an appearance of choroidal neovascularisation where there is none. These include projection artefacts from the superficial retinal vasculature, 80 or co-existing eye conditions such as pigment epithelial detachment, 46 that may mimic choroidal neovascularisation. The projection artefact tools on commercial OCT-A machines, albeit in the early stages of development, can in many cases remove these artefacts. Also, the anatomy and location of choroidal neovascularisation is markedly different from normal vessels. Careful comparison of these vascular patterns to those seen in presumed choroidal neovascularisation can avoid misinterpreting projection artefacts from these overlying superficial vessels as choroidal neovascularisation.
Studies have looked at the sensitivity and specificity of OCT-A in detecting different subtypes of choroidal neovascularisation. [81] [82] [83] [84] [85] Results depend on the characteristics of choroidal neovascularisation, but demonstrate a sensitivity of 81 per cent and specificity above 93 per cent. 13, 86 However, this included cases that had large degrees of subretinal haemorrhage. When cases of subretinal haemorrhage were excluded, sensitivity rose to 94 per cent and increased to 100 per cent when structural OCT data were used in conjunction with the OCT-A data. Failure to detect choroidal neovascularisation on OCT-A images is related to blockage of the OCT signal from overlying haemorrhage 86 and large pigment epithelial detachments, 84 causing a false negative result on OCT-A. Swept-source OCT-A systems have an advantage over spectral domain OCT-A systems, because they provide deeper tissue penetration due to longer wavelength and reduced sensitivity roll-off. Indeed, several studies have shown that choroidal neovascularisation area, when measured with swept-source OCT-A, is larger when compared with spectral domain OCT-A, due to improved visibility. [87] [88] [89] OCT-A is able to provide better details on the structural microvascular arrangement of choroidal neovascularisation when compared to fluorescein angiography, because the OCT signal is not blocked by leakage. Several groups have characterised the anatomy of small vessels and proposed methods to classify choroidal neovascularisation based on these features. 90, 91 OCT-A has also shown the shrinkage of choroidal neovascularisation after injection with anti-vascular endothelial growth factor (anti-VEGF) agents. 92, 93 By examining the sequential morphological changes of small vessels, the OCT-A may be a powerful tool, particularly in the diagnosis and monitoring of choroidal neovascularisation, and characterising the treatment response to intra-vitreal anti-VEGF injections. This may be an attractive approach for individualising retreatment schedules in patients after initial anti-VEGF loading doses. However, changes in retinal anatomy do occur in response to treatment. This would require a reliable and reproducible segmentation tool of progression images, which often requires manual segmentation, and is thus time consuming. A large-scale prospective study on this approach is required.
Applications in optic nerve head diseases
There has been a long-standing discussion as to the extent to which alterations in ocular blood flow and its regulation are associated with glaucomatous disease. 94, 95 Reduced blood flow can either be a causative factor for glaucoma and pre-dispose nerve fibres and retinal ganglion cells to damage, or a consequence of reduced metabolic demand due to loss of ganglion cells, or a combination of both. However, the lack of clarity surrounding the origin of vascular perfusion changes in glaucoma does not necessarily impact the potential usefulness of OCT-A imaging as a diagnostic tool for the disease. Studies employing OCT-A in glaucoma have focused on different regions of the posterior pole, including the peripapillary area, [96] [97] [98] the macular area, 98, 99 or the optic nerve head. [100] [101] [102] For example, Figure 5 presents disc photographs and OCT-A images in subtypes of angle closure across the disease severity, showing a greatly attenuated peripapillary vascular network in primary angle closure glaucoma ( Figure 5G-I ), compared to primary angle closure ( Figure 5D-F When studying the microvasculature of the optic nerve head, the complex vascular supply and the wide interindividual variability need to be considered, 103 which makes
OCT-A segmentation difficult. The complex remodelling of optic nerve head structures during the glaucomatous process needs to be considered. 104 Comparison of diagnostic performance between studies is challenging because different studies have included eyes with varying severity of glaucoma. It is clear that measures of diagnostic accuracy obtained from studies that include only patients with moderate or severe disease are not comparable to studies that include only patients in the early stage or suspects of the disease.
Little is known about the influence of blood pressure levels, intraocular pressure levels and ocular perfusion pressure on vessel density measurements. Since ocular perfusion pressure is the driving force of blood flow, it is expected that this will influence blood flow when values are outside the autoregulatory plateau. 105 With regard to blood pressure, long-term effects related to generalised capillary dropout and shortterm fluctuations need to be considered. It has been recently shown that in patients with systemic hypertension, higher levels of 24-hour ambulatory blood pressure are associated with reduced vessel density in the deeper retinal plexus. 60 However, there is currently no information on the shortterm fluctuations of blood pressure to vessel density. With regard to intraocular pressure, several studies have shown that surgical intraocular pressure reduction leads to an increase in vessel density, 106 ,107 most likely due to the increase in ocular perfusion pressure. In addition, it needs to be considered that some anti-glaucoma drugs have direct vasomotor effects 108 that can influence vessel density, although this is a topic which has received little attention. Finally, a wide variety of optic nerve head diseases also damage retinal ganglion cell axons, which are perfused by the radial peripapillary capillaries, leading to reduced vessel density as obtained with OCT-A. 109 This has been shown for optic nerve head drusen, 110 non-arteritic anterior ischaemic optic neuropathy [111] [112] [113] and optic neuritis. 114, 115 Therefore, the diagnostic performance of OCT-A as a stand-alone tool in glaucoma may have severe specificity issues because of reduced discriminative power over systemic as well as other optic nerve head 116 and retinal diseases.
OCT-A of the anterior segment
Compared to examining the posterior segment using OCT-A, application of this technique to the anterior segment has received relatively little attention. However, several groups have used posterior segment approaches with minor modifications of commercial systems and have been able to visualise anterior segment vasculature. 117 Anterior segment OCT-A has several potential clinical applications. The first obvious application is the objective delineation and potentially quantification of corneal vascularisation ( Figure 6 ). [118] [119] [120] [121] Importantly,
OCT-A of corneal neovascularisation has been validated against histology in animal models, 122 whereas this has not been achieved with posterior segment OCT-A. As the physiologically normal cornea is essentially avascular and receives oxygen from the air and the aqueous humour, pathological corneal vascularisation affects corneal transparency. Corneal vascularisation in the donor after corneal transplantation increases the rate of graft rejection. 123 Invasive angiography remains the gold standard for anterior segment vascular imaging. 124 However, this is not frequently performed in clinical settings because of potential side effects. 125 Therefore, there is an unmet clinical need for non-invasive imaging techniques for the anterior segment. Although rapidly performed and noncontact, OCT-A imaging of the cornea is associated with several challenges. 124, 126 First, motion artefacts occur as a result of excessive eye movements ( Figure 6E ). Eye tracking, commonly used for posterior segment OCT-A imaging, needs to be turned off because of the absence of sufficient anatomical landmarks. Corneal opacities such as scars may worsen the visibility of corneal vascularisation, particularly in the deeper layers of the cornea ( Figure 6C-F OCT-A en face image is able to delineate the abnormal corneal vascularisation, depth and extent within the lesion while planning for surgical dissection and diathermy or removal of the vessels. C: Colour slitlamp photograph showing abnormal corneal vascularisation and a calcified scar. D: Indocyanine green angiography is able to penetrate better and delineate the abnormal corneal vascularisation than OCT-A. E, F: OCT-A en face images showing extensive motion artefacts with E: auto-segmentation and F: manual segmentation is able to better improve the quality of the image, highlighting a barrier to accurate OCT-A imaging of the cornea and abnormal lesions.
OCT-A imaging requires re-scanning of the same retinal position multiple times. Therefore, imaging times are considerably longer than for structural OCT. OCT-A is unable to assess alterations in vascular permeability or leakage. The appearance of OCT-A images is highly dependent on the OCT-A device and processing algorithms, and results may not be comparable across instruments or image analysis. The interpretation of OCT-A images requires greater proficiency as the images can exhibit more artefacts than structural OCT images. 46 
Requirements to transform OCT-A to a clinical tool
The most clinically relevant application of OCT-A is related to the detection of choroidal neovascularisation. One clinical challenge to fully translate OCT-A into the clinical setting for the detection of choroidal neovascularisation may be that a significant number of cases of choroidal neovascularisation may be 'missed' when using OCT-A as compared to classical angiography.
Encouraging results have highlighted the potential utility of OCT-A in detecting subclinical macular neovascularisation in eyes with nonexudative age-related macular degeneration. This was associated with an increased conversion to exudative macular degeneration. 127 Eyes with nonexudative age-related macular degeneration were based on fundus examination and spectral domain-OCT imaging tests, defined as either intermediate agerelated macular degeneration (defined by the presence of drusen and pigmentary abnormalities in the central macula without evidence of geographic atrophy or exudation) or late age-related macular degeneration (defined by the presence of geographic atrophy in the absence of exudation). However, no prospective clinical trial has been performed providing evidence of the benefit for treating asymptomatic choroidal neovascularisation. The same is true when using OCT-A for anti-VEGF re-treatment criteria. Even though this approach is attractive in principle, there are currently no data to guide such a treatment regimen. Given the inclusion of OCT-A technology in several ongoing largescale trials, such results may be available in the near future. 128 Fortunately, advancements of OCT-A technology, segmentation and volume rendering will continually improve to minimise artefacts and enhance the visualisation of eyes with choroidal neovascularisation. However, reading of OCT-A scans will remain difficult for some ocular pathologies associated with severe haemorrhage. In these eyes, visibility may be better with invasive fluorescein angiography. Hence, a likely scenario is that OCT-A be used for the screening of choroidal neovascularisation in intermediate age-related macular degeneration in the future. Subsequently, eyes with unclear results can undergo fluorescein angiography to confirm a diagnosis of exudative age-related macular degeneration. The degree to which such an approach is costeffective needs to be determined.
Several investigators have proposed that OCT-A may have a role in the diagnosis of glaucoma. However, this may be difficult to implement because of the considerations presented earlier (see applications of optic nerve head diseases), inter-individual variability of optic nerve head microvasculature among healthy eyes, 103 remodelling of the optic nerve head during glaucoma 104 and challenges associated with comparing diagnostic performance studies. [96] [97] [98] [99] [100] [101] [102] Instead, OCT-A may be a viable clinical tool in glaucoma patients with high myopia, replacing structural OCT -the results of which are often biased by the abnormal anatomical configuration of the optic nerve head in highly myopic individuals. Several studies have focused on vessel density in glaucoma eyes with myopia. 102, 129 Shin et al. 129 showed that, in glaucoma patients with high myopia, peripapillary vessel density measured by OCT-A better correlated with visual field mean sensitivity than retinal nerve fibre layer thickness assessment. However, future use of OCT-A for glaucoma diagnosis in high myopes is likely to be undertaken in conjunction with structural imaging of the ganglion cell complex. 129 Even though anterior segment OCT-A has received little attention to date, imaging of corneal neovascularisation is among the most obvious applications of the technique. In contrast to evaluation at the slitlamp, OCT-A allows for objective measures of the extent and depth of angiogenesis. Therefore, OCT-A is an optimal approach for the follow-up of corneal neovascularisation. 123 
Conclusion
Despite the numerous clinical uses of OCT-A, there are no clear indications for OCT-A in a clinical setting. Most likely, identification of choroidal neovascularisation will be the first widespread application because the technique may be more cost-effective than invasive fluorescein angiography, which is a major advantage given the ever-increasing incidence of exudative age-related macular degeneration in the ageing population.
For the remaining ocular conditions, OCT-A may become an adjunct tool to provide information about vasculature. This is similar to the concept of multimodal imaging. Given that each imaging modality has its strengths and weaknesses, the use of a single imaging modality may not be optimal, and multimodal imaging may be a sensible approach to obtain the most reliable detection and measurement of disease progression. OCT-A has potent utility in this regard.
Finally, OCT-A provides novel insight into the pathophysiological processes of both retinal and optic nerve diseases, and will therefore remain an active area of research in the coming years.
